POMC and myeloid sarcoma: Evidence suggesting neuroprotective effects of ACTH/MCs (Strand and Kung, 1980; van der Neut et al., 1992; Catania, 2008), raises the possibility for a role of ACTH gel in treatment of progressive forms of MS.